Completed PHASE1 INTERVENTIONAL 1-arm NCT01539941

Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care

Sponsor: The National Center on Addiction and Substance Abuse at Columbia University

Conditions Adolescent Substance Abuse Attention Deficit Hyperactivity Disorder

Interventions Medication integration protocol

Updated 5 times since 2017 Last updated: Aug 3, 2015 Started: Aug 31, 2011 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01539941, this PHASE1 trial focuses on Adolescent Substance Abuse and Attention Deficit Hyperactivity Disorder and remains completed. Sponsored by The National Center on Addiction and Substance Abuse at Columbia University, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The National Center on Addiction and Substance Abuse at Columbia University

Data source: The National Center on Addiction and Substance Abuse at Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States